Showing 1 - 6 results of 6 for search 'Winfried Alsdorf', query time: 0.03s Refine Results
  1. 1
    Broadening the horizon: potential applications of CAR-T cells beyond current indications

    Broadening the horizon: potential applications of CAR-T cells beyond current indications by Hendrik Karsten, Ludwig Matrisch, Ludwig Matrisch, Sophia Cichutek, Walter Fiedler, Winfried Alsdorf, Andreas Block

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis

    Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis by Panagiotis Karagiannis, Lena Sänger, Winfried Alsdorf, Katja Weisel, Walter Fiedler, Stefan Kluge, Dominic Wichmann, Carsten Bokemeyer, Valentin Fuhrmann

    Published 2020-06-01
    Get full text
    Article
  3. 3
    Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?

    Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel? by Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, Anja Coym, Moritz Kaune, Stefan Werner, Markus Graefen, Carsten Bokemeyer, Lina Merkens, Sergey A. Dyshlovoy

    Published 2022-02-01
    Get full text
    Article
  4. 4
    958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

    958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors by John Haanen, Alexander Desuki, Andreas Mackensen, Ugur Sahin, Christian Koenecke, Winfried Alsdorf, Eva Wagner-Drouet, Daniel Heudobler, Peter Borchmann, Erol Wiegert, Catrine Schulz, Benjamin Rengstl, Liane Preussner, Oezlem Tuereci

    Published 2021-11-01
    Article
  5. 5
    Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer

    Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer by Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, Philipp Gild, Winfried Alsdorf, Moritz Kaune, Lukas Böckelmann, Jessica Hauschild, Christoph Krisp, Tina Rohlfing, Ceren Saygi, Malik Alawi, Alexandra Zielinski, Claudia Langebrake, Su Jung Oh-Hohenhorst, Sven Perner, Derya Tilki, Hartmut Schlüter, Markus Graefen, Sergey A. Dyshlovoy, Carsten Bokemeyer

    Published 2022-11-01
    Get full text
    Article
  6. 6
    959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial

    959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA2... by Harpreet Singh, Jason Luke, Mamta Kalra, Martin Wermke, Dejka Araujo, Ali Mohamed, Winfried Alsdorf, Apostolia-Maria Tsimberidou, Andrea Mayer-Mokler, Arun Satelli, Carsten Reinhardt, Dominik Maurer, George Jr Blumenschein, Kerstin Guenther, Manik Chatterjee, Norbert Hilf, Regina Mendrzyk, Steffen Walter, Stephen Eck, Tobias AW Holderried, Toni Weinschenk, Van Morris, Cedrik M Britten

    Published 2021-11-01
    Article

Search Tools: